Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 35,600 | 14,500 | 55,700 | 34,000 | 51,400 |
| Depreciation Amortization | 22,100 | 10,800 | 40,400 | 29,400 | 19,300 |
| Income taxes - deferred | 8,300 | 400 | -13,800 | -35,600 | -1,100 |
| Accounts receivable | -10,600 | -14,400 | -2,100 | -11,400 | -15,700 |
| Other Working Capital | -35,500 | -22,100 | -9,400 | -26,800 | -30,500 |
| Other Operating Activity | 19,400 | 14,000 | 79,700 | 83,800 | 19,300 |
| Operating Cash Flow | $39,300 | $3,200 | $150,500 | $73,400 | $42,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,400 | -2,200 | -36,600 | -22,000 | -13,500 |
| Net Acquisitions | -20,000 | -20,000 | -19,000 | N/A | N/A |
| Purchase Of Investment | -900 | -700 | -5,700 | -1,900 | -1,800 |
| Purchase Sale Intangibles | -9,100 | -1,300 | -7,000 | -4,800 | -2,900 |
| Other Investing Activity | -9,100 | -1,300 | -7,000 | -4,800 | -2,900 |
| Investing Cash Flow | $-42,400 | $-24,200 | $-68,300 | $-28,700 | $-18,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -200 | 2,500 | N/A | -400 | 400 |
| Debt Issued | 242,100 | 69,100 | 150,900 | 66,900 | 46,900 |
| Debt Repayment | -187,600 | -39,500 | -231,900 | -108,700 | -71,900 |
| Common Stock Issued | 23,500 | 3,600 | 13,700 | 10,800 | 7,400 |
| Common Stock Repurchased | -36,600 | -8,200 | -30,800 | -28,500 | -20,300 |
| Other Financing Activity | -4,400 | -300 | -1,300 | -1,700 | -1,100 |
| Financing Cash Flow | $36,800 | $27,200 | $-99,400 | $-61,600 | $-38,600 |
| Exchange Rate Effect | -17,200 | -10,600 | 3,700 | 8,200 | 1,900 |
| Beginning Cash Position | 34,200 | 34,200 | 47,700 | 47,700 | 47,700 |
| End Cash Position | 50,700 | 29,800 | 34,200 | 39,000 | 35,500 |
| Net Cash Flow | $16,500 | $-4,400 | $-13,500 | $-8,700 | $-12,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39,300 | 3,200 | 150,500 | 73,400 | 42,700 |
| Capital Expenditure | -18,000 | -7,800 | -40,700 | -24,900 | -16,400 |
| Free Cash Flow | 21,300 | -4,600 | 109,800 | 48,500 | 26,300 |